Danoprevir
未知生产厂商
Danoprevir has been used in trials studying the treatment of Hepatitis C, Chronic.
Danoprevir has been used in trials studying the treatment of Hepatitis C, Chronic.
Danoprevir is a NS3/4A protease inhibitor. The HCV NS3/4A protease is an attractive drug target because of its potential involvement in viral replication and suppressive effects on host response to viral infection. Inhibitors of the HCV protease, such as Danoprevir, represent a promising new class of drugs for HCV.
本品应与利托那韦、聚乙二醇干扰素α和利巴韦林联合组成抗病毒治疗方案，用于治疗初治的非肝硬化的基因1b型慢性丙型肝炎成人患者。
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
